Prestige Biologics Income Statement

Financials in millions KRW. Fiscal year is July - June.

Millions KRW. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2016 - 2020
Operating Revenue	12,533	2,169	1,746	15.57	3,227	Upgrade
Other Revenue	-	-	-0	-0	-	Upgrade
Revenue	12,533	2,169	1,746	15.57	3,227	Upgrade
Revenue Growth (YoY)	477.82%	24.24%	11115.88%	-99.52%	-	Upgrade
Cost of Revenue	28,517	11,013	1,252	24.28	880.08	Upgrade
Gross Profit	-15,984	-8,844	493.75	-8.71	2,347	Upgrade
Selling, General & Admin	8,992	9,695	7,639	5,202	3,770	Upgrade
Research & Development	2,588	9,301	31,848	30,970	25,097	Upgrade
Other Operating Expenses	340.46	417.59	237.71	180.45	82.61	Upgrade
Operating Expenses	17,698	24,586	40,536	36,623	29,184	Upgrade
Operating Income	-33,682	-33,430	-40,043	-36,631	-26,837	Upgrade
Interest Expense	-8,734	-11,769	-5,273	-3,929	-763.51	Upgrade
Interest & Investment Income	519.37	1,468	853.79	700.85	265.21	Upgrade
Currency Exchange Gain (Loss)	3,243	-4,690	-4,624	-9,537	296.68	Upgrade
Other Non Operating Income (Expenses)	11,191	18,957	10,222	257.62	-12,339	Upgrade
EBT Excluding Unusual Items	-27,463	-29,465	-38,863	-49,138	-39,378	Upgrade
Gain (Loss) on Sale of Assets	-6.86	90.87	67.29	66.42	-	Upgrade
Asset Writedown	-	-	-646.03	-646.03	-	Upgrade
Pretax Income	-27,469	-29,374	-39,442	-49,718	-39,378	Upgrade
Net Income	-27,469	-29,374	-39,442	-49,718	-39,378	Upgrade
Net Income to Common	-27,469	-29,374	-39,442	-49,718	-39,378	Upgrade
Shares Outstanding (Basic)	74	61	59	52	44	Upgrade
Shares Outstanding (Diluted)	74	61	59	52	44	Upgrade
Shares Change (YoY)	20.50%	4.32%	13.35%	16.43%	25.46%	Upgrade
EPS (Basic)	-372.51	-480.00	-672.37	-960.73	-885.98	Upgrade
EPS (Diluted)	-372.51	-480.00	-672.37	-960.73	-885.98	Upgrade
Free Cash Flow	-23,534	-16,867	-60,265	-118,767	-123,142	Upgrade
Free Cash Flow Per Share	-319.14	-275.63	-1027.35	-2295.00	-2770.62	Upgrade
Gross Margin	-127.53%	-	28.28%	-55.97%	72.73%	Upgrade
Operating Margin	-268.74%	-1541.23%	-2293.61%	-235333.31%	-831.68%	Upgrade
Profit Margin	-219.17%	-1354.23%	-2259.19%	-319407.01%	-1220.33%	Upgrade
Free Cash Flow Margin	-187.77%	-777.63%	-3451.94%	-763002.69%	-3816.18%	Upgrade
EBITDA	-20,598	-22,199	-31,629	-28,693	-22,916	Upgrade
EBITDA Margin	-164.35%	-	-	-	-	Upgrade
D&A For EBITDA	13,083	11,231	8,414	7,938	3,921	Upgrade
EBIT	-33,682	-33,430	-40,043	-36,631	-26,837	Upgrade
EBIT Margin	-268.74%	-	-	-	-	Upgrade
Advertising Expenses	101.46	308.97	-	53.15	39.82	Upgrade

Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.